Alert Clinic, HIV/AIDS Center, Addis Abeba, Ethiopia.
Acta Paediatr. 2011 Aug;100(8):1164-7. doi: 10.1111/j.1651-2227.2011.02243.x. Epub 2011 May 20.
To evaluate pediatric AntiRetroviral Treatment (ART) treatment in a resource-limited setting.
Data from a paediatric ART cohort at the All African Leprosy and Rehabilitation Centre, Addis Abeba, were analysed. Outcome measures included survival, age, gender, WHO stage, weight, regimen and CD4 cell count.
From April 2005 to December 2008, 482 children initiated ART. Median age was 5.9 years (IQR 3.7-9.8), and median CD4 cell count was 236 cells per mm3. Median follow-up was 16 months (IQR=6-24 month). Among those followed for 24 months (n=188), 160 children were still receiving treatment, six had dropped out, eight had been transferred out, and 13 (7.5%) had died (4.0 deaths per 100 person-years). Mortality was highest in the first 6 months resulting in a 4.3% mortality rate. Lower age and immune suppression (low CD4) were associated with mortality, while sex, drug regimen, tuberculosis at treatment initiation, application of stavudine and/or zidovudine were not.
ART treatment of children in resource-limited settings is possible as demonstrated by low attrition. The high proportion of malnourished children and children admitted at late stage of the disease calls for attention. Efforts to enrol more children and at an earlier stage of the disease should be promoted.
在资源有限的环境下评估儿科抗逆转录病毒治疗(ART)的疗效。
对全非麻风救济中心、亚的斯亚贝巴的儿科 ART 队列中的数据进行了分析。结局指标包括生存率、年龄、性别、世界卫生组织(WHO)分期、体重、方案和 CD4 细胞计数。
从 2005 年 4 月至 2008 年 12 月,482 名儿童开始接受 ART 治疗。中位年龄为 5.9 岁(IQR 3.7-9.8),中位 CD4 细胞计数为 236 个/立方毫米。中位随访时间为 16 个月(IQR=6-24 个月)。在随访 24 个月的 188 名儿童中,160 名仍在接受治疗,6 名失访,8 名转至其他机构,13 名(7.5%)死亡(4.0 人/100 人年)。前 6 个月的死亡率最高,导致死亡率为 4.3%。较低的年龄和免疫抑制(低 CD4)与死亡率相关,而性别、药物方案、治疗开始时患有结核病、应用司他夫定和/或齐多夫定与死亡率无关。
在资源有限的环境下,为儿童提供 ART 治疗是可行的,且治疗的脱落率较低。营养不良儿童和晚期就诊儿童比例较高,需要引起重视。应努力让更多的儿童更早地接受治疗。